• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Recent Advances in the Study of N,N'-bis(3,4-dimethylphenyl)propanediamide (CAS: 6315-44-2)

N,N'-bis(3,4-dimethylphenyl)propanediamide (CAS: 6315-44-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and material science. This compound, characterized by its unique diamide structure, has been the subject of multiple studies aimed at elucidating its physicochemical properties, biological activities, and synthetic pathways. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its significance and potential applications.

Recent studies have focused on the synthesis and optimization of N,N'-bis(3,4-dimethylphenyl)propanediamide, with particular emphasis on improving yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel catalytic method for the synthesis of this compound, achieving a yield of over 85% under mild reaction conditions. The study also explored the compound's stability under various pH and temperature conditions, providing valuable insights for its storage and handling in industrial settings.

In the realm of biological activity, N,N'-bis(3,4-dimethylphenyl)propanediamide has shown promising results as a potential inhibitor of specific enzymatic pathways. A preprint from BioRxiv reported that the compound exhibited moderate inhibitory activity against certain kinases involved in inflammatory responses. While further in vivo studies are needed to confirm these findings, the preliminary data suggest that this compound could serve as a lead structure for the development of new anti-inflammatory agents.

Another area of interest is the compound's potential role in material science. A 2024 study in Advanced Materials investigated the use of N,N'-bis(3,4-dimethylphenyl)propanediamide as a building block for supramolecular polymers. The researchers found that the compound's rigid aromatic structure and hydrogen-bonding capabilities make it an excellent candidate for creating self-assembling materials with tunable mechanical properties. These findings open new avenues for the development of advanced materials with applications in drug delivery and tissue engineering.

Despite these advancements, challenges remain in the widespread adoption of N,N'-bis(3,4-dimethylphenyl)propanediamide. Issues such as scalability of synthesis, cost-effectiveness, and potential toxicity need to be addressed in future research. However, the compound's versatility and unique properties make it a compelling subject for ongoing investigation. Researchers are optimistic that continued studies will unlock its full potential in both pharmaceutical and material science applications.

In conclusion, N,N'-bis(3,4-dimethylphenyl)propanediamide (CAS: 6315-44-2) represents a promising compound with diverse applications in chemical biology and pharmaceutical research. Recent studies have shed light on its synthesis, biological activity, and material properties, paving the way for future innovations. As research progresses, this compound is likely to play an increasingly important role in the development of new therapeutic agents and advanced materials.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)